Young woman with mobile phone drinking alcohol in bed.

“Excessive drinking and alcohol use disorder is the biggest drug problem in the world”

According to John Mendelson, MD, Chief Medical Officer of Ria Health (formerly DxRx Medical), a digital health startup focused on helping people with alcohol abuse excessive drinking and alcohol use disorder is the biggest drug problem in the world. During my interview with him, he went on to say,

It is estimated that one in ten people have a bad relationship with alcohol…they drink more than they should, they are unable to control their intake, they are unable to stop when they want, they do things that they don’t want while drinking, and they have harm from their drinking.

Alcohol abuse disorder is a progressive disorder. “It starts with heavy drinking in their 30’s and it progresses on in their 40’s to having measurable problems with their families, with their work and with legal issues. Virtually..everyone who has had a DUI has a drinking problem.

 

Alcoholic abuse is common and it is serious

There are serious and even fatal consequences of the disorder including medical sequelae such as liver failure, pancreatitis, brain disorders, heart rhythm disturbances. There are also injuries and deaths due to drunk driving, falls, and fights. Despite alcohol abuse being a common and serious disease, “in the United States and the rest of the world, these problems are largely unaddressed.

There are a number of reasons why alcohol abuse has not been addressed as much as it should. First of all, there is a stigma to having an alcohol problem that makes people reluctant to talk about it even with their physicians. In his remarkable opinion piece published in the March 23, 2017, issue of the New England Journal of Medicine, Adam Hill, a pediatric palliative care physician and recovering alcoholic with a history of depression and suicidal thoughts, puts it this way,

“Alcoholics are stereotyped as deadbeats or bums…an alcoholic isn’t a bum under a bridge or an abusive spouse: I am the face of alcoholism…it is ironic that mental health conditions are so stigmatized in the medical profession…when mental health conditions come too close to us, we tend to look away – or to look with pity, exclusion, or shame.”

Dr. Mendelson thinks that another reason alcohol abuse hasn’t been addressed adequately is that

“the recovery community has insisted that abstinence is the only outcome that is meaningful.”

But, he says, “there is a lot of data that says that is not the case. For example, for people who go into abstinence-based treatment programs after 5 years, 80% of people are drinking, but they are drinking less. So it is a problem that can get better…abstinence isn’t the only pathway.

 

Medication-assisted treatment

Although vastly underutilized, there are a number of drugs that can be used to help people control their drinking, including naltrexone and acamprosate. There are many studies that show that medications can decrease the number of days of heavy drinking in people seeking treatment or decrease the number of heavy drinking days.

According to Dr. Mendelson,

“When people drink…almost everyone stops drinking….when you go out with your friends to have wine, you have some wine, some beer, or some alcohol and you stop at some point. What’s that point? That point is when you are happy, you are intoxicated, but you are not having any bad aversive reactions. You are not slurring your words, you are not stumbling, you don’t feel bad, you don’t feel out of control. That set point, that point between how much you take and when you stop is actually biologically determined and it’s amenable to medication. What the medications appear to do is to decrease the amount of pleasure you get from drinking—they don’t decrease it severely. You can still have enjoyment, but they decrease it enough so that the signals stop to emerge sooner.”

Ria Health uses naltrexone as the first choice medication in their treatment program. It has been approved by the FDA for the treatment of people who want to control their drinking. Mendelson says that “it appears to work by blocking opiate receptors. It turns out when you drink, some of the pleasure is caused by the release of opiates in the brain. If you block that part of the pleasure, you don’t drink as much.

Joseph Volpicelli, MD, Ph.D., Associate Professor of Psychiatry at the University of Pennsylvania School of Medicine and an expert in the treatment of alcoholism, explains it this way,

“Naltrexone sort of gets at the core of what addiction is. The way I like to describe it is that addiction is a condition in which when you do something, you want to do more and more of it.”

Instead of stopping after a few drinks, people with alcohol use disorder want to have more and more and more drinks. Dr. Volpicelli says that naltrexone seems to break that positive feedback loop so that people can have one or two drinks and then stop because they don’t feel like having any more.

 

The value proposition of Ria Health Medical

I asked Dr. Mendelson why people should use DxRx Medical (now Ria Health) instead of just going to their primary care physician and getting a prescription for naltrexone. He said the problem with that approach is that people don’t usually know how much they are drinking so it is hard to figure out if the medication is helping them to cut back. Also, the drug doesn’t work for everybody. To overcome this obstacle to effective treatment, the DxRx program monitors people’s drinking by having them use a breathalyzer paired to a smartphone twice a day—in the morning when they wake up and in the evening before they go to bed. That way they can actually quantify the impact of the program on the participant’s alcohol consumption.

Because Ria Health is a telemedicine service, it is more convenient and less time-consuming than other types of alcohol treatment programs. It is also more private. Participants are contacted via telephone to determine the goal of treatment:

“Do they want to control their drinking? Do they want to get to the point where they can be social drinkers again—defined as consistent blood alcohol concentrations of below .08? Or do they want abstinence?”

Some patients do choose abstinence,” Mendelson says, “and the ones who wanted abstinence have gotten there.” Also, the ones who want controlled drinking have had a “pretty good response.” The ones who don’t respond may be on the wrong medication or, perhaps, some were not that motivated to start with. Finally, some people have more severe disease and may need residential treatment.

Everyone in the program receives a breathalyzer and picks up their medication prescription at a local pharmacy. Before starting the medication, the breathalyzer is used for two to three days in order to obtain some baseline data. That way, “we get objective proof that you are improving.

Participants are also asked to take “pill photos”—taking a picture of the pill in your hand just before you take it – so that adherence to the treatment can be ascertained. Mendelson says that his lab “pioneered this method of automating this particular technology to measure adherence to medications.” And, he says, “it does work. People will take pill photos and pill photos are directly related to whether they take the pills or not.

If adherence starts trailing off or alcohol levels start going up, Ria Health staff will contact the patient to suggest a change of medication. It turns out, he says, that “there are actually six medications that have adequate phase two evidence, showing decreased days of heavy drinking or decreased heavy drinking days in the medical literature.

Ria Health charges $99/month for the program. Mendelson notes that amount is less than most people are spending on alcohol every month. Right now, he says, they are looking for six months of continuous treatment based on the literature: “the FDA feels, based on medication trials, that six months of change represents an adequate change to say that it is going to go to the future.

Although they do not have formal research to validate outcomes yet—the program just started a less than a year ago—they do have breathalyzer data from their first cohort of patients who have been with them for 30 days. These data document a 60% reduction in alcohol use from baseline.

John closed the interview by saying that they are often asked about Alcoholics Anonymous (AA)…why not just go to AA? “We are big supporters of AA. We think you should go to AA if it works for you…

But we offer something on top of AA, that is very useful – that is suppression of alcohol intake…

so you end up with the ability to make the choice to go to AA, to seek abstinence, or just get your life back together and keep moving forward while drinking in a controlled fashion.

Currently, Ria Health is only offered in California, but you can sign up on their website to be notified when it expands into other areas.

LEAVE A REPLY


All comments are moderated. Please allow at least 1-2 days for it to display.